A study finds fewer reactions and increased speed in OIT for milk allergy while using the medication omalizumab.
After six months of treatment, more than 80 percent of the children taking the therapy were able to eat at least five peanuts a day
A monoclonal antibody halted the production of peanut-specific IgE in peanut-allergic mice and in blood samples from people with peanut… Read more »
Updated June 8 – Researchers are enrolling participants in a study to determine whether people with severe allergies or a… Read more »
Dupilumab Led to Asthma Remission for Some About 30 percent of patients taking the biologic drug dupilumab experienced “remission” of… Read more »
In a small study, sublingual immunotherapy (SLIT) was effective in desensitizing peanut-allergic toddlers, allowing 74 percent to consume 4,443 milligrams… Read more »
Rewards, reaction risks and potential for milk allergy and egg allergy resolution with the introduction of baked foods.
In our Holiday e-magazine, Allergic Living hears from food allergy moms who show phenomenal creativity. They share how to make “home for the holidays” a magical time, despite the pandemic. This e-magazine brims with allergy-friendly invention – from holiday tours to PJ parties, side-dish dinners, family book nights and ultimate Zoom special occasions.
“Science is showing us the path to a future in which new therapeutic options may provide both solutions as well… Read more »